|
We study the cell biology of endocrine and neuroendocrine cells. Our
work focuses on the mechanisms of biosynthesis and intracellular trafficking
of peptide hormones and neuropeptides and their processing enzymes. Our
studies have led to the discovery of novel molecular mechanisms of protein
trafficking to the regulated secretory pathway and of recycling of sorting
receptors as well as to the understanding of diseases related to defects
in hormone targeting. We have also identified a master on/off switch that
regulates dense-core granule biogenesis in neuro-endocrine and endocrine
cells.
Mechanism of Sorting Pro-Neuropeptides to the
Regulated Secretory Pathway
Cawley, Zhang, Dhanvantari, Rodriguez-David, Arnaoutova,
Loh
The intracellular sorting of pro-neuropeptides to the regulated secretory
pathway (RSP) is essential for processing, storage, and release of active
hormones in the neuroendocrine cell. We thus investigated the sorting
of pro-opiomelanocortin (POMC, pro-ACTH/endor-phin) and pro-enkephalin
(proEnk) to the RSP. We showed that, as a concentration step, these pro-proteins
undergo homotypic oligomerization as they traverse the cell from the site
of synthesis in the endoplasmic reticulum to the trans-Golgi network (TGN);
there, they are sorted into dense-core granules of the RSP for processing
and secretion. Site-directed mutagenesis studies identified a consensus
sorting motif consisting of two acidic residues 1215Å apart
and exposed on the surface of these molecules and two hydrophobic residues
57Å away from the acidic residues, which are necessary for
sorting to the RSP. We identified an RSP sorting receptor that was specific
for the sorting signal of POMC and proEnk as membrane carboxipeptidase
E (CPE). The two acidic residues in the prohormone sorting motif specifically
interact with two basic residues, R255 and K260, of the CPE sorting receptor
to effect sorting to the RSP.
We showed that CPE is a transmembrane protein that is anchored in the
TGN via its C-terminal amphipathic tail to unique cholesterol-glycosphingolipidrich
microdomains known as rafts. Removal of cholesterol from secretory granule
membranes resulted in the inability of CPE to bind to cargo; by treating
cells with lovastatin, cholesterol depletion resulted in lack of sorting
of CPE and POMC to the RSP. Thus, membrane association is essential for
the prohormone sorting receptor function of CPE at the TGN. Transfection
of CPE bearing R255A and K260A mutations into a CPE null clone of Neuro2a
cells and transfection of a dominant negative CPE construct into AtT20
cells caused missorting of POMC to the constitutive pathway, indicating
that the basic residues in the sorting domain of CPE interact with the
acidic residues in the POMC sorting signal in
vivo to effect sorting to the RSP. Using a mouse model that synthesizes
a mutant CPE, which is degraded in the pituitary, we were able to show
missorting of endogenous POMC in these neuroendocrine cells. Our studies
provide evidence for a sorting signal/receptor-mediated mechanism for
targeting prohormones to the RSP in neuro-endocrine cells.
Sorting of Proinsulin Mutants in Hyperpro-insulinemia
Patients
Dhanvantari, Zhang, Loh; in collaboration with
Mackin, Morris
Investigations into the sorting of proinsulin in pancreatic
b-cells has identified an RSP sorting signal in proinsulin similar
to POMC. In monomeric proinsulin, the sorting signal motif consists of
residues E13 and L17 located on the B chain and L16 and E17 located on
the A chain. In hexameric proinsulin, residue E13 on the B chain is buried,
and two residues in the A chain from two adjacent proinsulin dimers in
the hexamer contribute a motif. Depletion of CPE in these pancreatic cells
with siRNA and the use of a dominant negative CPE construct demonstrated
that CPE acts as a sorting receptor for proinsulin in b-cells.
Furthermore, the binding of proinsulin and insulin to membrane CPE has
pH optima of pH 6.5 and 5.5, respectively. We have proposed a sorting
by retention model for proinsulin sorting in b-cells,
which differs from the sorting by entry model for POMC sorting
in neuroendocrine cells. In b-cells, proinsulin
binds to CPE at the TGN pH of 6.5 and is sorted into immature secretory
granules (ISG). However, other nonRSP proteins such as the lysosomal
enzymes also enter the ISG in b-cells. Proinsulin
is then released from CPE in the ISG and processed to insulin. Insulin
then rebinds CPE at the more acidic pH of the ISG and is retained while
other non-RSP proteins are removed from the ISG by a constitutive-like
pathway (Fig. 22). To understand the molecular basis of hyperproinsu-linemia,
we investigated the intracellular sorting of genetically mutated proinsulins
found in such diabetes patients who, by definition, have abnormally high
levels of plasma proinsulin. One form of mutant proinsulin found in the
patients, HisB10Asp, which is unable to hexamerize but forms dimers, missorted
to the constitutive pathway and was secreted in an unregulated manner
when transfected into a cell line. Molecular modeling of the dimer of
this mutant proinsulin predicted that the molecular distance between the
two acidic residues of the RSP sorting signal motif would be too large
to allow interaction with the basic residues in the binding site of the
sorting receptor, CPE. Indeed, in vitro
binding studies showed that the mutant did not bind to CPE, resulting
in its inability to be sorted to the RSP for processing to insulin and
secretion in a secretogogue-dependent manner.

FIGURE 22
| Schematic diagram showing a model of proinsulin trafficking
to the regulated secretory pathway in b-cells. |
Other hyperproinsulinemia proinsulin mutants R65P and R65L were also
secreted constitutively and were not stored. Binding studies showed that
mutant R65P and R65L proinsulins bound poorly to CPE, accounting for the
lack of sorting and retention in the ISG (Fig. 22). The high levels of
secreted mutant proinsulins in the plasma of the hyperproinsulinemia patients
are therefore attributable to defects in sorting of these molecules as
a consequence of their genetic structural alterations.
Sorting and Recycling of the Sorting Receptor
CPE
Zhang, Dhanvantari, Arnoutova, Loh; in collaboration
with Donaldson, Jackson
Our studies showed that CPE, a transmembrane protein, is sorted into granules
of the RSP in neuroendocrine cells by a mechanism involving insertion
of its C-terminal domain into lipid rafts at the TGN. Upon stimulation
and exocytosis, membrane CPE is localized on the plasma membrane and remains
associated with rafts. It is subsequently recycled back to the TGN by
a novel internalization mechanism. The inter-nalization of CPE from the
plasma into early endosomes requires not only functional ARF6, a GTPase,
but also physical interaction of ARF6 with the six-amino-acid cytoplasmic
tail of CPE.
Regulation of Secretory Granule Biogenesis
Kim, Loh; in collaboration with Eiden, Cheng
Formation of large dense-core granules (LDCG) at the TGN is essential
for regulated secretion of hormones and neuropeptides from neuroendocrine
cells. Our recent studies uncovered a master on/off switch, chromogranin
A (CgA), that controls the formation of LDCG in neuroendocrine cells.
Using antisense technology, we observed that depletion of CgA in rat PC12
cells resulted in the loss of LDCG and regulated secretion, and led to
degradation of the granule proteins CgB and synapto-tagmin. Over-expression
of bovine CgA in the same cells rescued the wild-type phenotype. In a
mutant endocrine cell line, 6T3, which lacks CgA, LDCGs, and regulated
hormone secretion, transfection of CgA restored the wild-type phenotype.
Recently, we used microarrays to compare gene expression in 6T3 cells
lacking LDCGs with 6T3 cells stably transfected with CgA. We found that
the aquaporin 1 (AQP1, a water channel) and the granuphilin genes were
highly up-regulated in 6T3 cells expressing CgA, indicating a new role
of CgA at the transcriptional level. While it is known that granulphilin
is present in LDCGs and is important in exocytosis, the subcellular localization
and role of AQP1 in endocrine cells is unclear. We have now shown that
6T3 cells transfected with CgA and pituitary and chromaffin cell secretory
granules contain high levels of AQP1 protein. Thus, AQP1 may be important
in regulating secretory granule volume during granule maturation and exocytosis.
|
|
SELECTED PUBLICATIONS
- Cawley NX, Chino M, Maldonado A, Rodriguez YM, Loh YP, Ellman J.
Synthesis and characterization of the first potent inhibitor of yapsin
1: implications for the study of yapsin-like enzymes. J Biol Chem. 2002;
(e-pub ahead of print).
- Cawley NX, Loh YP. Yapsin 1. In: Barrett AJ, Woessner JF, eds. Handbook
of proteolytic enzymes, 2d ed. London: Academic Press, 2002;in press.
- Dhanvantari S, Arnaoutova I, Snell CR, Steinbach PJ, Hammond K, Caputo
GA, London E, Loh YP. Carboxypeptidase E, a prohormone sorting receptor,
is anchored to secretory granules via a C-terminal transmembrane insertion.
Biochemistry. 2002;41:52-60.
- Dhanvantari S, Cawley NX, Loh YP. Prohormone convertases. In: Martini
L, ed. The encyclopedia of endocrinology and endocrine diseases. 2002;in
press.
- Kim T, Tao-Cheng JH, Eiden LE, Loh YP. Chromogranin A, an on/off
switch controlling dense-core granule biogenesis. Cell. 2001;106:499-509.
- Kim T, Tao-Cheng JH, Eiden LE, Loh YP. Large dense-core secretory
granule biogenesis is under the control of chromogranin A in neuroendocrine
cells. Ann NY Acad Sci. 2002;971:323-331.
- Loh YP, Cawley NX, Yapsin A. In: Barrett AJ, Woessner JF, eds. Handbook
of proteolytic enzymes, 2d ed. London: Academic Press, 2002;in press.
- Loh YP, Maldonado A, Zhang CF, Tam WH, Cawley NX. Mechanism of sorting
pro-opiomelanocortin and pro-enkephalin to the regulated secretory pathway
of neuroendocrine cells. Ann NY Acad Sci. 2002;971:416-425.
- Volpi S, Rabadan-Diehl C, Cawley NX, Aguilera G. Transcriptional
regulation of the pituitary vasopressinV1b receptor involves a GABA
binding protein. J Biol Chem. 2002;277:27829-27838.
COLLABORATORS
Julie Donaldson, Ph.D., Laboratory of Cell Biology,
NHLBI, Bethesda, MD
Lee Eiden, Ph.D., Laboratory of Cellular and Molecular
Recognition, NIMH, Bethesda, MD
Cathy Jackson, Ph.D., Cell Biology and Metabolism
Branch, NICHD, Bethesda, MD
Robert Mackin, Ph.D., Creighton University School
of Medicine, Omaha, NE
Stephen Morris, Ph.D., Aegera Therapeutics, Montreal,
Canada
Jung Hwa Tao-Cheng, Ph.D., Electron Microscope
Facility, NINDS, Bethesda, MD
|